IL59628A - 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them - Google Patents

4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them

Info

Publication number
IL59628A
IL59628A IL59628A IL5962880A IL59628A IL 59628 A IL59628 A IL 59628A IL 59628 A IL59628 A IL 59628A IL 5962880 A IL5962880 A IL 5962880A IL 59628 A IL59628 A IL 59628A
Authority
IL
Israel
Prior art keywords
esters
salts
amino
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL59628A
Other languages
English (en)
Other versions
IL59628A0 (en
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of IL59628A0 publication Critical patent/IL59628A0/xx
Publication of IL59628A publication Critical patent/IL59628A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL59628A 1979-03-26 1980-03-14 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them IL59628A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (2)

Publication Number Publication Date
IL59628A0 IL59628A0 (en) 1980-06-30
IL59628A true IL59628A (en) 1983-06-15

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
IL59628A IL59628A (en) 1979-03-26 1980-03-14 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them

Country Status (31)

Country Link
US (1) US4343804A (forum.php)
JP (1) JPH02117663A (forum.php)
AR (1) AR230268A1 (forum.php)
AT (1) AT372373B (forum.php)
AU (1) AU528388B2 (forum.php)
BR (1) BR8001779A (forum.php)
CA (1) CA1147338A (forum.php)
CH (1) CH644105A5 (forum.php)
DE (1) DE3011490A1 (forum.php)
DK (1) DK156056C (forum.php)
EG (1) EG15009A (forum.php)
ES (1) ES489887A0 (forum.php)
FI (1) FI77452C (forum.php)
FR (1) FR2452485B1 (forum.php)
GB (1) GB2047244B (forum.php)
GR (1) GR68006B (forum.php)
HK (1) HK67983A (forum.php)
IE (1) IE49577B1 (forum.php)
IL (1) IL59628A (forum.php)
IN (1) IN151446B (forum.php)
IT (1) IT1133079B (forum.php)
MX (1) MX6264E (forum.php)
NL (1) NL8001752A (forum.php)
NO (1) NO153927C (forum.php)
NZ (1) NZ193252A (forum.php)
PH (1) PH16416A (forum.php)
PL (1) PL125030B1 (forum.php)
PT (1) PT71008B (forum.php)
SE (1) SE435837B (forum.php)
SG (1) SG33683G (forum.php)
YU (1) YU41702B (forum.php)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
JP3980052B2 (ja) * 1993-08-10 2007-09-19 ジェイムズ・ブラック・ファウンデーション・リミテッド ガストリンとcckレセプタリガンド
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
NZ510580A (en) 1998-09-29 2003-03-28 American Cyanamid Co Substituted 3-cyanoquinolines useful as protein tyrosine kinases inhibitors
MXPA02006474A (es) * 1999-12-28 2002-11-29 Eisai Co Ltd Compuestos heterociclicos que contienen sulfonamida.
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
NZ540612A (en) 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
KR101179012B1 (ko) 2003-03-10 2012-09-03 니코메드 게엠베하 로플루미라스트 신규한 제조 방법
KR20060056944A (ko) * 2003-07-14 2006-05-25 아레나 파마슈티칼스, 인크. 대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료
JP5383183B2 (ja) * 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
WO2011022216A1 (en) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
CN108558740B (zh) 2010-01-27 2021-10-19 艾尼纳制药公司 S1p1受体调节剂及其盐的制备方法
MX2013003184A (es) 2010-09-22 2013-06-07 Arena Pharm Inc Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo.
EP4445956A3 (en) 2015-01-06 2024-12-04 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
AU2016284162A1 (en) 2015-06-22 2018-02-01 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(Compound1) for use in SIP1 receptor-associated disorders
MY196327A (en) * 2016-11-11 2023-03-24 Bayer Animal Health Gmbh New Anthelmintic Quinoline-3-Carboxamide Derivative
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
EP3700527A4 (en) * 2017-10-25 2021-03-10 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHOD OF USING THEM
EP3790874B1 (en) 2018-05-09 2023-03-15 Bayer Animal Health GmbH Anthelmintic quinoline derivatives
WO2019236757A1 (en) 2018-06-06 2019-12-12 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
JPS4838712A (forum.php) * 1971-09-18 1973-06-07

Also Published As

Publication number Publication date
DK156056C (da) 1989-11-06
AR230268A1 (es) 1984-03-01
DE3011490C2 (forum.php) 1988-12-22
IT1133079B (it) 1986-07-09
YU41702B (en) 1987-12-31
HK67983A (en) 1983-12-23
US4343804A (en) 1982-08-10
NO153927C (no) 1986-06-18
FR2452485A1 (fr) 1980-10-24
GB2047244B (en) 1983-02-23
DK128380A (da) 1980-09-27
FI800910A7 (fi) 1980-09-27
IE800605L (en) 1980-09-26
GR68006B (forum.php) 1981-10-26
ES8103048A1 (es) 1981-02-16
EG15009A (en) 1985-03-31
IT8067465A0 (it) 1980-03-26
IN151446B (forum.php) 1983-04-23
FI77452C (fi) 1989-03-10
AT372373B (de) 1983-09-26
ATA156480A (de) 1983-02-15
PL222993A1 (forum.php) 1981-01-30
PT71008A (en) 1980-04-01
IL59628A0 (en) 1980-06-30
BR8001779A (pt) 1980-11-18
PT71008B (en) 1981-06-25
GB2047244A (en) 1980-11-26
NL8001752A (nl) 1980-09-30
JPH02117663A (ja) 1990-05-02
IE49577B1 (en) 1985-10-30
NZ193252A (en) 1984-04-27
YU84480A (en) 1983-10-31
SE435837B (sv) 1984-10-22
SG33683G (en) 1985-03-29
SE8002292L (sv) 1980-09-27
FR2452485B1 (fr) 1986-09-12
ES489887A0 (es) 1981-02-16
DE3011490A1 (de) 1981-03-12
CA1147338A (en) 1983-05-31
AU5684880A (en) 1980-10-02
CH644105A5 (fr) 1984-07-13
PL125030B1 (en) 1983-03-31
AU528388B2 (en) 1983-04-28
FI77452B (fi) 1988-11-30
MX6264E (es) 1985-02-19
NO153927B (no) 1986-03-10
DK156056B (da) 1989-06-19
NO800858L (no) 1980-09-29
PH16416A (en) 1983-09-29

Similar Documents

Publication Publication Date Title
IL59628A (en) 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them
IL56991A0 (en) 4-halo-3-oxoandrost-4-ene-17 -thiocarboxylic acid esters their preparation and pharmaceutical compositions containing them
IL60422A (en) Formylhydroxyphenoxy pentanoic and methylbenzoic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL64185A0 (en) 1-carboxy-azaalkanoylindoline-2-carboxylic acids and ester and amide derivatives thereof,their manufacture and pharmaceutical compositions containing them
IL78528A0 (en) Difluoro-naphthyridine-and trifluoro-quinoline-carboxylic acids and esters and salts thereof and pharmaceutical compositions containing them
NZ189296A (en) N-substituted-omega-aminoalkanoyl-omega-aminoalkanoic acids and pharmaceutical compositions
DE3064453D1 (en) Isoquinoline acetic acids and pharmaceutical compositions thereof
NZ190842A (en) 4-substituted-thiazole-2-oxamic acids and esters and pharmaceutical compositions
ZA822933B (en) Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation
IL61210A (en) 3-benzoyl-2-nitrophenylacetic acids and metal salts,amides and esters thereof and pharmaceutical compositions containing them
GB2057427B (en) Oxoimidazolinealkanoic acids and their salts and esters their preparation and pharmaceutical compositions containing them
NZ190521A (en) Phenylamino-thiophenacetic acids and pharmaceutical compositions
IL52820A0 (en) New acylated heterocyclylcarboxylic acids and salts thereof their preparation and pharmaceutical compositions containing them
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
IL55152A0 (en) 7-acylamido-3-cephem-4-carboxylic acids and esters and salts thereof,their preparation and pharmaceutical compositions containing them
NZ194241A (en) 7b-aminothiadiazolylacetamido-3-cephem-4 carboxylic acid derivatives and pharmaceutical compositions
NZ185511A (en) 2-(2-amidoethylidene)-clavam-3-carboxylic acids salts and esters and pharmaceutical compositions
DE2967551D1 (en) 5(6)-(2-amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them
JPS5692843A (en) Nnsubstituted alphaaamino acids*their manufacture and medicinal composition containing them
NZ194122A (en) Acylaminobenzoic acid derivatives and pharmaceutical compositions
PH14995A (en) Oxaminic acids and esters thereof and pharmaceutical compositions containing these compounds
NZ187474A (en) 4-heterocyclyl-piperazine-i-carbodithioic acids and salts and pharmaceutical compositions thereof
NZ189295A (en) N-substituted-acyl-aminoalkanoic acids and pharmaceutical compositions
IL52952A0 (en) New hydroxymethyl-pyridine esters their preparation and pharmaceutical compositions containing them
IL58154A0 (en) 1-methyl-4-piperidinol esters their preparation and pharmaceutical compositions containing them